Post Profile






Related Posts


New Immunotherapy Approved for Metastatic Bladder Cancer

Health : Mayo Clinic News Blog

Patients with metastatic bladder cancer have few treatment options after failure of chemotherapy until now. In early May, the U.S. Food and Drug Administration (FDA) approved the immunological drug Atezolizumab to treat metastatic b...

F.D.A. Approves an Immunotherapy Drug for Bladder Cancer

Health : NYTimes: Health

The drug, Tecentriq from Roche, works by using the body’s immune system against tumors, and is the first drug of its type approved for bladder cancer.

The FDA just approved a revolutionary kind of drug to treat bladder cancer for the first time

Business & Finance : Business Insider: Clusterstock

The FDA on Wednesday approved a new kind of drug to treat the most common form of bladder cancer. The drug, which goes by the name Tecentriq and was developed by Genentech, is a cancer immunotherapy. Unlike chemotherapy, which invol...

Medical News Today: FDA approve immunotherapy drug for bladder cancer

Health : Medical News Today

The FDA have given accelerated approval to Tecentriq (atezolizumab), a PD-1/PD-L1 inhibitor, to treat urothelial carcinoma, the most common type of bladder cancer.

Bladder Cancer Research Rife with New Approaches

Health : Newswise Medical News

The FDA approval of Tecentriq ushered in the first new treatment for advanced bladder cancer in 30 years.

Comments


Copyright © 2016 Regator, LLC